These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7907185)

  • 21. Treatment of aggression in patients with bipolar disorder.
    Swann AC
    J Clin Psychiatry; 1999; 60 Suppl 15():25-8. PubMed ID: 10418811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mood-stabilizer-maintained, remitted bipolar patients: taper and discontinuation of adjunctive antipsychotic medication.
    Saksa JR; Baker CB; Woods SW
    Gen Hosp Psychiatry; 2004; 26(3):233-6. PubMed ID: 15121352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacotherapy in bipolar disorder].
    Nolen WA
    Ned Tijdschr Geneeskd; 1999 Jun; 143(25):1299-305. PubMed ID: 10416483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients.
    Malempati RN; Bond DJ; Yatham LN
    Int Clin Psychopharmacol; 2008 Mar; 23(2):88-94. PubMed ID: 18301123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of the combination of lithium and neuroleptic drugs.
    Goldney RD; Spence ND
    Am J Psychiatry; 1986 Jul; 143(7):882-4. PubMed ID: 2872825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Biel MG; Peselow E; Mulcare L; Case BG; Fieve R
    Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsychotics in bipolar disorder.
    Gelenberg AJ; Hopkins HS
    J Clin Psychiatry; 1996; 57 Suppl 9():49-52. PubMed ID: 8823350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polypharmacy in bipolar I disorder.
    Solomon DA; Keitner GI; Ryan CE; Miller IW
    Psychopharmacol Bull; 1996; 32(4):579-87. PubMed ID: 8993078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New treatment for bipolar disorder in children and adolescents: learning from adult studies].
    Soutullo Esperón C; Barroilhet S; Landecho Acha I; Ortuño Sánchez-Pedreño F
    Actas Esp Psiquiatr; 2003; 31(1):40-7. PubMed ID: 12590372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of rapid-cycling bipolar disorder.
    Schneck CD
    J Clin Psychiatry; 2006; 67 Suppl 11():22-7. PubMed ID: 17029493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical antipsychotics for bipolar disorder.
    Yatham LN
    Psychiatr Clin North Am; 2005 Jun; 28(2):325-47. PubMed ID: 15826735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticonvulsants in bipolar disorder.
    Singh V; Muzina DJ; Calabrese JR
    Psychiatr Clin North Am; 2005 Jun; 28(2):301-23. PubMed ID: 15826734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision tree for the treatment of bipolar disorder.
    Sachs GS
    J Clin Psychiatry; 2003; 64 Suppl 8():35-40. PubMed ID: 12892540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial triple therapy of acute mania, adding lithium and valproate to neuroleptics.
    Reischies FM; Hartikainen J; Berghöfer AM
    Pharmacopsychiatry; 2002 Nov; 35(6):244-6. PubMed ID: 12518274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment-resistant bipolar disorder.
    Gitlin M
    Mol Psychiatry; 2006 Mar; 11(3):227-40. PubMed ID: 16432528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decision model for the acute treatment of mania.
    Steffens DC; Krishnan KR
    Depress Anxiety; 1996-1997; 4(6):289-93. PubMed ID: 9166657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium neurotoxicity at low therapeutic doses Hypotheses for causes and mechanism of action following a retrospective analysis of published case reports.
    Emilien G; Maloteaux JM
    Acta Neurol Belg; 1996 Dec; 96(4):281-93. PubMed ID: 9008777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic neuroleptic exposure in bipolar outpatients.
    Sernyak MJ; Godleski LS; Griffin RA; Mazure CM; Woods SW
    J Clin Psychiatry; 1997 May; 58(5):193-5. PubMed ID: 9184612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modifications of lymphocyte HL-A antigens as a consequence of therapy in patients with manic-depressive psychosis].
    Májský A; Dvoráková M; Zvolský P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):509-17. PubMed ID: 83272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Complications observed during use of lithium salt-neuroleptic combinations; comparative study of clinical evolution, EEG and pharmacokinetics].
    Granier F; Girard M; Loustalan JM; Thomas J; Escande M
    Ann Med Psychol (Paris); 1983; 141(8):891-908. PubMed ID: 6141759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.